Stockscreener 앱 받기
22.62
3.33%
-0.78
전일 마감가:
$23.40
열려 있는:
$23.46
하루 거래량:
552.57K
시가총액:
$2.05B
수익:
-
순이익/손실:
$-245.60M
주가수익비율:
-6.8338
EPS:
-3.31
순현금흐름:
$-211.39M
1주 성능:
-0.44%
1개월 성능:
-4.48%
6개월 성능:
+3.05%
1년 성능:
+4.92%
1일 변동 폭
$22.45
$23.56
52주 변동 폭
$14.89
$32.52
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
명칭
Rocket Pharmaceuticals Inc
전화
646-440-9100
주소
430 East 29th Street, Suite 1040, New York, NY
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 개시 | Morgan Stanley | Overweight |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2022-11-01 | 개시 | BTIG Research | Buy |
| 2022-07-08 | 개시 | Raymond James | Outperform |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 개시 | JP Morgan | Overweight |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2019-11-06 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-26 | 개시 | Piper Jaffray | Overweight |
| 2019-04-23 | 개시 | Robert W. Baird | Outperform |
| 2019-03-15 | 개시 | BofA/Merrill | Buy |
| 2019-02-05 | 개시 | Oppenheimer | Outperform |
| 2018-09-13 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-10 | 개시 | William Blair | Outperform |
모두보기
Rocket Pharmaceuticals Inc 주식(RCKT)의 최신 뉴스
Rocket Pharmaceuticals Inc (RCKT)'s stock chart: A technical perspective – US Post News - US Post News
US Post News
Los Angeles Capital Management LLC Purchases 10538 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Defense World
Q2 2024 Earnings Estimate for Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Issued By Leerink Partnrs - MarketBeat
MarketBeat
Rocket Pharmaceuticals (RCKT) Presents Positive Data from LV Hematology Portfolio - StreetInsider.com
StreetInsider.com
Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the ... - Business Wire
Business Wire
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) to Post Q2 2024 Earnings of ($0.71) Per Share, William Blair Forecasts - MarketBeat
MarketBeat
Rocket Pharmaceuticals Inc (RCKT) 재무 분석
Rocket Pharmaceuticals Inc (RCKT) 순이익 2024
RCKT은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -245.59M 달러로 보고했으며, 전년대비 -10.70% 감소했습니다.
Rocket Pharmaceuticals Inc (RCKT) 현금흐름 2024
2023-12-31 종료 분기에 RCKT은 현금흐름(지난 12개월)으로 -211.39M 달러를 기록했으며, 전년 대비 -13.19% 감소했습니다.
Rocket Pharmaceuticals Inc (RCKT) 주당 순이익 2024
RCKT이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -2.94달러이며, 전년 대비 +9.82% 성장했습니다.
Rocket Pharmaceuticals Inc 주식 (RCKT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SOUTHWELL DAVID P | Director |
Apr 15 '24 |
Option Exercise |
4.34 |
29,624 |
128,627 |
124,784 |
| SOUTHWELL DAVID P | Director |
Apr 15 '24 |
Sale |
24.05 |
10,000 |
240,520 |
114,784 |
| SOUTHWELL DAVID P | Director |
Apr 12 '24 |
Option Exercise |
4.34 |
70,000 |
303,940 |
165,160 |
| SOUTHWELL DAVID P | Director |
Apr 12 '24 |
Sale |
24.36 |
70,000 |
1,705,265 |
95,160 |
| White Mark Andrew | See Remarks |
Apr 08 '24 |
Sale |
24.64 |
12,532 |
308,763 |
75,226 |
| Makker Gotham | Director |
Mar 21 '24 |
Sale |
28.43 |
274,000 |
7,790,943 |
365,912 |
| Militello John | See Remarks |
Mar 21 '24 |
Sale |
28.10 |
2,490 |
69,979 |
55,239 |
| Militello John | See Remarks |
Feb 29 '24 |
Option Exercise |
12.55 |
10,000 |
125,500 |
31,517 |
| Militello John | See Remarks |
Feb 29 '24 |
Sale |
29.84 |
10,000 |
298,450 |
21,517 |
| Wilson Martin | General Counsel |
Feb 29 '24 |
Sale |
29.33 |
4,100 |
120,257 |
18,680 |
0.77%
1.20%
자본화:
|
볼륨(24시간):